metricas
covid
Clinics Neutralizing activity against Omicron subvariants BA.1, BA.2, and BA.4/5 followi...
Journal Information

Statistics

Follow this link to access the full text of the article

Original articles
Neutralizing activity against Omicron subvariants BA.1, BA.2, and BA.4/5 following the third SARS-CoV-2 vaccination in cancer patients undergoing chemotherapy
Jina Yuna, Bora Kima, Hyuk Kima, Sung Hee Limb, Seong Hyeok Choia, Ji Youn Kima, Hyun Jung Kima, Seong Kyu Parka,
Corresponding author
skpark@schmc.ac.kr

Corresponding author.
a Division of Hematology-Oncology, Department of Medicine, Soonchunhyang University, Bucheon Hospital, Bucheon, Gyeonggi-do, South Korea
b Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, South Korea
Read
383
Times
was read the article
73
Total PDF
310
Total HTML
Share statistics
Article information
ISSN: 18075932
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 34 4 38
2025 11 136 32 168
2025 10 34 5 39
2025 9 74 14 88
2025 8 32 18 50

Follow this link to access the full text of the article